No Data
No Data
Jefferies Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7
William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA)
BioAge Labs | 10-K: FY2024 Annual Report
BioAge Labs | 8-K: BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
BioAge Labs FY24 EPS $(6.63) Up From $(38.17) YoY
BioAge Labs: Existing Cash and Cash Equivalents Sufficient to Fund Ops and Cap Expenses Through 2029 >BIOA